Open Access
Issue
BIO Web Conf.
Volume 127, 2024
The International Conference and Workshop on Biotechnology (ICW Biotech 2024)
Article Number 04001
Number of page(s) 7
Section Integration of Nutrition, Food Security, and Vaccine Development
DOI https://doi.org/10.1051/bioconf/202412704001
Published online 13 September 2024
  • Scriba, T.J. and V. Mizrahi, Renewing the Fight Against TB with an Old Vaccine. Cell, 2020. 180(5): p. 829–831. [CrossRef] [PubMed] [Google Scholar]
  • Poyntz, H.C., et al., Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. Tuberculosis (Edinb), 2014. 94(3): p. 226–37. [CrossRef] [PubMed] [Google Scholar]
  • Brandt, L., et al., Failure of the Mycobacterium bovis BCG Vaccine: Some Species of Environmental Mycobacteria Block Multiplication of BCG and Induction of Protective Immunity to Tuberculosis. Infection and Immunity, 2002. 70(2): p. 672–678. [CrossRef] [PubMed] [Google Scholar]
  • Woodworth, J.S., et al., A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin. Nat Commun, 2021. 12(1): p. 6658. [CrossRef] [PubMed] [Google Scholar]
  • Hoang, T., et al., ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for preand postexposure tuberculosis vaccination. PLoS One, 2013. 8(12): p. e80579. [CrossRef] [PubMed] [Google Scholar]
  • Lewis, K.N., et al., Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation. J Infect Dis, 2003. 187(1): p. 117–23. [CrossRef] [PubMed] [Google Scholar]
  • Ligon, L.S., J.D. Hayden, and M. Braunstein, The ins and outs of Mycobacterium tuberculosis protein export. Tuberculosis, 2012. 92(2): p. 121–132. [CrossRef] [PubMed] [Google Scholar]
  • Pym, A.S., et al., Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Molecular Microbiology, 2002. 46(3): p. 709–717. [CrossRef] [PubMed] [Google Scholar]
  • Rawat, S.S., et al., Immunoinformatics Approaches for Vaccine Design: A Fast and Secure Strategy for Successful Vaccine Development. Vaccines (Basel), 2023. 11(2). [PubMed] [Google Scholar]
  • Oli, A.N., et al., Immunoinformatics and Vaccine Development: An Overview. Immunotargets Ther, 2020. 9: p. 13–30. [CrossRef] [Google Scholar]
  • Chen, X., J.L. Zaro, and W.C. Shen, Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev, 2013. 65(10): p. 1357–69. [CrossRef] [PubMed] [Google Scholar]
  • Abramson, J., et al., Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature, 2024. 630(8016): p. 493–500. [CrossRef] [PubMed] [Google Scholar]
  • Doytchinova, I.A. and D.R. Flower, VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics, 2007. 8: p. 4. [CrossRef] [PubMed] [Google Scholar]
  • Ponomarenko, J., et al., ElliPro: a new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics, 2008. 9: p. 514. [CrossRef] [PubMed] [Google Scholar]
  • Biavasco, R. and M. De Giovanni, The Relative Positioning of B and T Cell Epitopes Drives Immunodominance. Vaccines, 2022. 10. [Google Scholar]
  • Shawan, M., et al., Advances in Computational and Bioinformatics Tools and Databases for Designing and Developing a Multi-Epitope-Based Peptide Vaccine. Int J Pept Res Ther, 2023. 29(4): p. 60. [CrossRef] [PubMed] [Google Scholar]
  • Mortazavi, B., A. Molaei, and N.A. Fard, Multi-epitopevaccines, from design to expression; an in silico approach. Hum Immunol, 2024. 85(3): p. 110804. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.